Back to Trades
Keyoung Hansoo Michael
DirectorCIK 0001824764
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025
Keyoung Hansoo Michael, Director, has filed 1 SEC report (2025), all concentrated in Kairos Pharma, LTD. (KAPA), totaling $0 in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.